NCL Issues a Second Alert to Heed Warnings About Unregulated Versions of GLP-1 Weight Loss Drugs Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 Washington, DC A year ago, the National Consumers League took the unusual step of flagging warnings from the Food and Drug Administration (FDA) and medical societies stating that compounded versions of GLP-1 (glucagon-like peptide-1 receptor agonists) weight-loss drugs are not FDA approved and may cause serious health problems
Emotions, Food & Nutrition 00:02:30 Attraction & Aversion 00:03:38 Vagus Nerve, Sugar 00:06:31 Sponsor: Function 00:08:19 Gut Feelings, Hidden Sugars, Amino Acids 00:10:43 Dopamine, Craving, L-tyrosine 00:14:45 Serotonin, Carbohydrates 00:17:59 Sponsor: AG1 00:19:36 Tool: Omega-3s
When you first start a personalized program through us, your provider gradually increases your dose
Effective management of diarrhoea during retatrutide treatment begins with dietary and lifestyle modifications, which are generally the first-line approach for gastrointestinal side effects associated with incretin-based therapies
Whether your goal is to gain lean muscle, lose fat, or simply feel and sleep better, this peptide combo offers fast action + long-term balance
